BioNTech is a German biotechnology company headquartered in Mainz, focused on mRNA vaccines, immunotherapy and infectious diseases. Its Comirnaty COVID-19 vaccine, developed with Pfizer, proved the potential of mRNA technology, and the company is now applying that platform to cancer vaccines in clinical trials.
BioNTech faces declining vaccine revenue and patent disputes over mRNA technology.